Recommended in Pulmonology

  • Clinical Essentials from J Clin Oncol
  • no comment
  • FULLTEXT

Stage IV NSCLC: new ASCO guidelines for systemic therapy

Recommendations include data from 20 new clinical trials.

Read more
  • Vitals
  • 1 comment

Respiratory Infection Vitals for August 2017

Read more
  • Clinical Essentials from Ann Surg
  • 1 comment

VATS vs open lobectomy: which is better for Stage 1 NSCLC?

Read more
  • Clinical Essentials from Eur J Cancer
  • 1 comment

Nonsmoker lung cancer on the rise in UK

Read more
  • Univadis
  • 1 comment

ASCO 2017 - Advanced SCLC: promising results with nivolumabĀ±ipilimumab

Read more
  • Univadis
  • no comment

ASCO 2017 - Extensive-stage SCLC after chemotherapy: favorable OS with pembrolizumab in phase 2 trial

Read more
  • Univadis
  • 1 comment

ASCO 2017 - NSCLC: phase 3 study suggests prolonged survival benefit with atezolizumab

Read more
  • Clinical Essentials from Chest
  • 1 comment

Lung cancer: surgery within 37 d of diagnosis offers best survival

Read more
  • Univadis
  • 1 comment

ASCO 2017 - Phase 2 data support first immunotherapy for mesothelioma

Read more

Professional Essentials

  • Patients Will Be Asking

Should I expose my allergic child to peanuts?

Read more
  • US Professional News
  • FULLTEXT

Illinois pediatrician fires anti-vax parents

Read more
  • US Professional News
  • FULLTEXT

Connecticut physicians launch their own health information exchange

Read more
  • US Professional News
  • FULLTEXT

What's playing in the OR: patient song requests

Read more
  • Patients Will Be Asking

Is binge watching TV bad for me?

Read more
  • US Professional News
  • FULLTEXT

Most physicians OK with single payer

Read more
View more

New in Pulmonology

  • Clinical Essentials from PLoS One
  • 1 comment
  • FULLTEXT

Asthma medications: systematic review of pediatric adverse events

Asthma medications are frequently prescribed to children even without a clear-cut diagnosis.

Read more
  • Clinical Essentials from Lung Cancer
  • 1 comment

Malignant mesothelioma: up to 30% of US patients remain untreated

SEER analysis shows that only about 60% of patients receive life-extending systemic treatment.

Read more
  • Clinical Essentials from Acad Pediatr
  • 1 comment

Pediatric asthma: effect of consistently impaired outcomes

Children with asthma with poor PROs have daytime sleepiness, impaired school function.

Read more
  • Clinical Essentials from J Asthma
  • 1 comment

Nighttime asthma symptoms: which medication?

Nighttime asthma awakenings may be frequently undercontrolled in general practice.

Read more
  • Clinical Essentials from Vaccine
  • 1 comment

Pediatric CAP cases with high bacterial infection values drop after PCV13 introduction

Overall decline in CAP cases continues.

Read more
  • Clinical Essentials from Eur J Cancer
  • 1 comment
  • FULLTEXT

Advanced NSCLC: carboplatin is noninferior to higher-dose cisplatin

Randomized phase 3 trial compares carboplatin vs cisplatin added to gemcitabine.

Read more
  • Clinical Essentials from Obstet Gynecol
  • 1 comment

Sleep disorders during pregnancy may increase risk for preterm delivery

Further study is needed to understand this potential relationship.

Read more
  • Clinical Essentials from Lung Cancer
  • 1 comment

NSCLC: treatment delay does not affect survival

Findings challenge guidelines recommending treatment within 31 d of diagnosis.

Read more
  • Clinical Essentials from Int J Chron Obstruct Pulmon Dis
  • 1 comment
  • FULLTEXT

COPD and mucoactives: the evidence for carbocysteine

No prior meta-analyses have evaluated the long-term use of carbocysteine in COPD.

Read more
  • Clinical Essentials from Lung Cancer
  • 1 comment

Refractory NSCLC: add-on ramucirumab extends OS, PFS

REVEL study shows benefit for adding ramucirumab to 2nd-line docetaxel.

Read more
Lung Cancer Vitals for August 2017
  • Vitals
  • 1 comment

Lung Cancer Vitals for August 2017

Alectinib in ALK-positive NSCLC | PBT plus adjuvant chemo in unresectable advanced NSCLC.

Read more
  • Clinical Essentials from JAMA Neurol
  • 1 comment

Dementia: study underscores role of midlife vascular risk factors

Middle-aged adults with modifiable vascular risk factors are more likely to develop dementia in later life.

Read more
  • Clinical Essentials from PLoS One
  • no comment
  • FULLTEXT

SCLC tied to 8-fold increased risk for paraneoplastic syndromes

Compared with the general population, risk was 8-fold higher in SCLC and 5-fold higher in NSCLC.

Read more
  • Clinical Essentials from Respir Med
  • 1 comment

COPD and pedometers: adding motivation

Daily step count for 3 mo yields better data than measuring activity at specific points.

Read more